ipol (poliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus
sanofi pasteur inc. - poliovirus type 1 antigen (formaldehyde inactivated) (unii: 0lvy784c09) (poliovirus type 1 antigen (formaldehyde inactivated) - unii:0lvy784c09), poliovirus type 2 antigen (formaldehyde inactivated) (unii: 23je9kdf4r) (poliovirus type 2 antigen (formaldehyde inactivated) - unii:23je9kdf4r), poliovirus type 3 antigen (formaldehyde inactivated) (unii: 459rom8m9m) (poliovirus type 3 antigen (formaldehyde inactivated) - unii:459rom8m9m) - poliovirus type 1 antigen (formaldehyde inactivated) 40 [d'ag'u] in 0.5 ml - ipol vaccine is indicated for active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus types 1, 2, and 3. (28) it is recommended that all infants (as young as 6 weeks of age), unimmunized children, and adolescents not previously immunized be vaccinated routinely against paralytic poliomyelitis. (29) following the eradication of poliomyelitis caused by wild poliovirus from the western hemisphere (including north and south america) (30), an ipv-only schedule was recommended to eliminate vapp. (7) all children should receive four doses of ipv at ages 2, 4, 6 to 18 months, and 4 to 6 years. opv is no longer available in the us and is not recommended for routine immunization. (7) previous clinical poliomyelitis (usually due to only a single poliovirus type) or incomplete immunization with opv are not contraindications to completing the primary series of immunization with ipol vaccine. children of all ages should have their immuni
covid-19 vaccine (vero cell), inactivated 6.5u/dose injection
g42 medication trading license llc china - 3 glass vials (double dose/vial -1 ml ) - injection - 6.5u/dose - immunologicals , vaccines-vaccines , antisera
covid-19 vaccine (vero cell), inactivated 6.5u/dose injection
g42 medication trading license llc china - 10 vials (5-dose /vial- 2.5ml) - injection - 6.5u/dose - immunologicals , vaccines-vaccines , antisera
covid-19 vaccine (vero cell), inactivated 6.5u/dose injection
g42 medication trading license llc china - 3 glass vials (double dose/vial -1 ml ) - injection - 6.5u/dose - immunologicals , vaccines-vaccines , antisera
covid-19 vaccine (vero cell), inactivated 6.5u/dose injection
g42 medication trading license llc china - 10 glass vials/box (single dose/vial -0.5 ml) - injection - 6.5u/dose - immunologicals , vaccines-vaccines , antisera
covid-19 vaccine (vero cell), inactivated 6.5u/dose injection
g42 medication trading license llc china - 1 glass vial (0.5 ml) - injection - 6.5u/dose - immunologicals , vaccines-vaccines , antisera
covid-19 vaccine (vero cell), inactivated 6.5u/dose injection
g42 medication trading license llc china - 1 pre-filled syringe (0.5 ml) - injection - 6.5u/dose - immunologicals , vaccines-vaccines , antisera
covid-19 vaccine (vero cell), inactivated 6.5u/dose injection
g42 medication trading license llc china - 10 glass vials/box (double dose/vial -1 ml) - injection - 6.5u/dose - immunologicals , vaccines-vaccines , antisera
covid-19 vaccine (vero cell), inactivated 6.5u/dose injection
g42 medication trading license llc china - 1 double dose/vial (1 ml) - injection - 6.5u/dose - immunologicals , vaccines-vaccines , antisera
covid-19 vaccine (vero cell), inactivated 6.5u/dose injection
g42 medication trading license llc china - 10 vials (5-dose /vial- 2.5ml) - injection - 6.5u/dose - immunologicals , vaccines-vaccines , antisera